Presented by M. Kumi Smith, PhD
Abstract: This is an exciting time in HIV prevention. Encouraging results from clinical trials of interventions such as preexposure prophylaxis (PrEP) or treatment as prevention (TasP) have fueled calls for the end of the HIV epidemic. As with many advances, scale up from carefully controlled trials to population-level programs presents substantial obstacles. This is nowhere more the case than in resource constrained settings where local conditions can limit our ability to take full advantage of cutting edge science. Dr. Kumi Smith’s talk will share insights from her work in China and other global settings, which bridge gaps between clinical science and the real world by facilitating implementation of PrEP and TasP in the places where they may have the greatest impact.